openPR Logo
Press release

Anthrax Key Players : Altimmune Inc, Aphios Corp, Crestone Inc, Green Cross Corp, Hawaii Biotech Inc, iBio Inc, Syntiron LLC Market Analysis and Forecast 2018-2022

02-06-2018 07:27 AM CET | Health & Medicine

Press release from: WISE GUY RESEARCH CONSULTANTS PVT. LTD.

/ PR Agency: Wise Guy Research Consultants Pvt. Ltd
Anthrax

Anthrax

WiseGuyReports.com with their unique quality of simplifying the market research study presents a deep diving study report “Anthrax - Pipeline Review, H1 2018”

Overview

Anthrax is a serious infectious disease caused by Bacillus anthraces. Signs and symptoms include nausea, vomiting, abdominal pain, headache, and loss of appetite, fever, severe, bloody diarrhea in the later stages of the disease, sore throat and difficulty swallowing. Risk factors include inject illegal drugs, handle animal skins and work in veterinary medicine, especially dealing with livestock.

It is primarily a disease of grazing animals such as cattle, sheep, goats, and horses. Pigs are more resistant, as are dogs and cats. Birds usually are naturally resistant to anthrax. Buzzards and vultures are naturally resistant to anthrax but may transmit the spores on their talons and beaks.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811468-anthrax-pipeline-review-h1-2018  

Anthrax Industry Major Highlights:

Anthrax - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Anthrax (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases

The report further guide in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Anthrax (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Apart from this various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Major Outlook for Anthrax Report:

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Anthrax (Infectious Disease) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Anthrax (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews the latest news related to pipeline therapeutics for Anthrax (Infectious Disease).

The pipeline guide provides a snapshot of the global therapeutic landscape of Anthrax (Infectious Disease).

- The pipeline guide reviews pipeline therapeutics for Anthrax (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

Competitive Analysis for Anthrax

Key players are making innovative developments in Anthrax industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector.

The key players in this market are ActiveSite Pharmaceuticals Inc, Coherus BioSciences Inc, Lupin Ltd, Mabion SA, OMEICOS Therapeutics GmbH, Promedior Inc, Taiwan Liposome Company Ltd and Xbrane Biopharma AB.

….. Continued

Table of Contents

Introduction 5

Global Markets Direct Report Coverage 5

Anthrax - Overview 6

Anthrax - Therapeutics Development 7

Pipeline Overview 7

Pipeline by Companies 8

Products under Development by Companies 10

Anthrax - Therapeutics Assessment 11

Assessment by Target 11

Assessment by Mechanism of Action 13

Assessment by Route of Administration 15

Assessment by Molecule Type 17

Anthrax - Companies Involved in Therapeutics Development 19

ActiveSite Pharmaceuticals Inc 19

Coherus BioSciences Inc 19

Lupin Ltd 20

Mabion SA 20

....

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2811468-anthrax-pipeline-review-h1-2018

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anthrax Key Players : Altimmune Inc, Aphios Corp, Crestone Inc, Green Cross Corp, Hawaii Biotech Inc, iBio Inc, Syntiron LLC Market Analysis and Forecast 2018-2022 here

News-ID: 932208 • Views:

More Releases from WISE GUY RESEARCH CONSULTANTS PVT. LTD.

CBD Snack Market 2020- Global Industry Analysis, By Key Players, Segmentation, Trends and Forecast By 2026
CBD Snack Market 2020- Global Industry Analysis, By Key Players, Segmentation, T …
Summary: A new market study, titled “Discover Global CBD Snack Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports. Introduction “CBD Snack Market” COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and
Chronic Lymphocytic Leukemia Global Key Players 4SC AG, AbbVie Inc, Baliopharm AG, Celltrion Inc, Debiopharm International SA, Eli Lilly and Co, Market Analysis and Forecast 2017-2022
Chronic Lymphocytic Leukemia Global Key Players 4SC AG, AbbVie Inc, Baliopharm A …
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2017” Chronic lymphocytic leukemia (CLL) Overview Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the bone marrow. It then invades the blood. Symptoms usually develop slowly. Symptoms of CLL include abnormal bruising (if platelets are low), fever, infections
Onychomycosis (Tinea Unguium) Global Key Players Almirall SA, Blueberry Therapeutics Ltd, Dermala Inc, Hexima Ltd Kaken, Pharmaceutical Co Ltd Market Analysis and Forecast 2018-2022
Onychomycosis (Tinea Unguium) Global Key Players Almirall SA, Blueberry Therapeu …
WiseGuyReports.com with their unique quality of simplifying the market research study presents a deep diving study report “Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2018” Onychomycosis (Tinea Unguium) Overview Onychomycosis is a chronic fungal infection of the nails caused by dermatophytes. Symptoms include thickened nail that is difficult to cut, brittle or ragged nail, discolored or unsightly nail and pain of the finger or toe with ordinary activities. Treatment includes antifungal medications and
Non Alcoholic Fatty Liver Disease Global Key Players Akcea Therapeutics Inc, Betagenon AB, Cadila Healthcare Ltd, Daewoong Pharmaceutical Co Ltd, Eli Lilly and Co Market Analysis and Forecast 2018-2022
Non Alcoholic Fatty Liver Disease Global Key Players Akcea Therapeutics Inc, Bet …
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2018” Non Alcoholic Fatty Liver Disease (NAFLD) Overview Non Alcoholic Fatty Liver Disease (NAFLD) this situation arise when individual have too much fats there your liver. There should be little or no fat in a healthy liver and for most people, carrying a small amount of

All 5 Releases


More Releases for Anthrax

Anthrax Vaccines Market to Witness Robust Expansion by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anthrax Vaccines market. Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against
Anthrax Vaccine Market : A Complete Guide On Global Anthrax Vaccine Market And I …
Global Anthrax Vaccine Market Precision Business Insights (PBI) in its report titled “Global Anthrax Vaccine Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Anthrax is a bacterial infection caused by Bacillus
Anthrax Vaccines Market Competitive Landscape Analysis with Forecast by 2025
Anthrax is a severe infectious disease caused by spores of a gram-positive bacterium called Bacillus anthracis. It generally infects through four routes viz. the lungs, the intestines, the skin, and injectable. Anthrax affects both humans and animals, especially ruminants such as cattle, sheep, goats, and horses. It does not easily spread from one person to another. Signs and symptoms of anthrax vary depending on the type of infection. Cutaneous anthrax,
Anthrax Market Competitive Landscape Analysis with Forecast by 2025
Anthrax is a lethal disease affecting humans as well as animals such as goat, sheep, horses, and cattle. The causative agent is a gram positive, rod shaped bacterium Bacillus anthracis. Anthrax can spread through three main routes which include aerial route, digestive route and contact through skin. Common symptoms in human beings for respiratory infection include pneumonia and severe respiratory collapse. Gastrointestinal infection is associated with symptoms such as vomiting,
Anthrax - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Anthrax - Pipeline Review, H1 2017, provides an overview of the Anthrax (Infectious Disease) pipeline landscape. Anthrax is a serious infectious disease caused by Bacillus anthracis. Signs and symptoms include nausea, vomiting, abdominal pain, headache, loss of appetite, fever, severe, bloody diarrhea in the later stages of the disease, sore throat and difficulty swallowing. Risk factors include inject illegal drugs, handle animal skins
Anthrax Vaccines Market 2017- Merial, Merck, Zoetis
Apex Research, recently published a detailed market research study focused on the "Anthrax Vaccines Market" across the global, regional and country level. The report provides 360° analysis of "Anthrax Vaccines Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Anthrax Vaccines industry, and estimates the future trend of Anthrax Vaccines market on